Diagnosing comorbidity in psychiatric hospital: challenging the validity of administrative registers

Abstract

BackgroundThis study will explore the validity of psychiatric diagnoses in administrative registers with special emphasis on comorbid anxiety and substance use disorders.MethodsAll new patients admitted to psychiatric hospital in northern Norway during one year were asked to participate. Of 477 patients found eligible, 272 gave their informed consent. 250 patients (52%) with hospital diagnoses comprised the study sample. Expert diagnoses were given on the basis of a structured diagnostic interview (M.I.N.I.PLUS) together with retrospective checking of the records. The hospital diagnoses were blind to the expert. The agreement between the expert’s and the clinicians’ diagnoses was estimated using Cohen’s kappa statistics.ResultsThe expert gave a mean of 3.4 diagnoses per patient, the clinicians gave 1.4. The agreement ranged from poor to good (schizophrenia). For anxiety disorders (F40-41) the agreement is poor (kappa = 0.12). While the expert gave an anxiety disorder diagnosis to 122 patients, the clinicians only gave it to 17. The agreement is fair concerning substance use disorders (F10-19) (kappa = 0.27). Only two out of 76 patients with concurrent anxiety and substance use disorders were identified by the clinicians.ConclusionsThe validity of administrative registers in psychiatry seems dubious for research purposes and even for administrative and clinical purposes. The diagnostic process in the clinic should be more structured and treatment guidelines should include comorbidity.

Detecting Neuroimaging Biomarkers for Depression: A Meta-analysis of Multivariate Pattern Recognition Studies

“…Multiple studies reported changes in brain structure (77) and function (82)(83)(84) following chronic antidepressant treatment. If such effects are present in neuroimagingbased classification experiments, the brain patterns identified might be associated with drugeffects rather than with effects specific to the pathology of depression.…”

“…For example, the recent investigation of the test-retest reliability of the diagnostic categories of the DSM V, indicated that MDD was diagnosed with limited accuracy (81). Similarly, MDD and bipolar disorder might frequently be confused (82). In effect, misclassification in the initial psychiatric assessment might have contributed to reductions in classification performance.…”

Prevalence, Employment Rate, and Cost of Schizophrenia in a High-Income Welfare Society: A Population-Based Study Using Comprehensive Health and Welfare Registers

“…Diagnoses of psychotic disorders in the NPR also have not yet been subjected to formal validity testing, but a recent report comparing clinical and research-based diagnostic evaluations demonstrated good agreement for schizophrenia. 51 Costs of medications are limited to antipsychotics as reliable data on other medications were not available. We could not access reliable data regarding the criminal justice system costs associated with schizophrenia.…”

Neurocognitive and functional correlates of mobile phone use in middle-aged and older patients with schizophrenia

“…The ability to use a telephone is considered one of the instrumental activities of daily living, and mobile phones are rapidly replacing land-line telephones as an “everyday technology”(Czaja et al, 2006). Furthermore, a number of interventions focusing on schizophrenia have used mobile phone to extend psychosocial interventions to the community, delivered through either live communication with a provider, text messages, or smartphone applications, with intervention foci reminders or prompts to engage in self-management activities outside of the clinic setting (Depp et al, 2010; Palmier-Claus et al, 2013) or elements of evidence-based treatments such as cognitive behavioral therapy for SMI (Ben-Zeev et al, 2014; Granholm, Ben-Zeev, Link, Bradshaw, & Holden, 2012). Thus, mobile phone use can be viewed as an increasingly relevant indicator of functional status and as a potential conduit to intervention in schizophrenia.…”